A new dawn for stem-cell therapy.
Higgs
Douglas R
DR
Weatherall Institute of Molecular Medicine, Medical Research Council Molecular Haematology Unit, John Radcliffe Hospital, Oxford, United Kingdom.
D000755:Anemia, Sickle Cell / Q000628:therapy*; D000818:Animals; D065150:Cellular Reprogramming; D004195:Disease Models, Animal; D053595:Embryonic Stem Cells; D005347:Fibroblasts / Q000166:cytology*; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000166:cytology; D006650:Histocompatibility Testing; D006801:Humans; D051379:Mice; D039904:Pluripotent Stem Cells / Q000166:cytology*; D014161:Transduction, Genetic